Gut Colonization With Carbapenem-Resistant Enterobacteriaceae in COVID-19-Recovered Patients: A Prospective Observational Study
Priyam Batra, Ajisha Aravindan, Priyankar K Datta, Sumit Roy Chowdhury, Rama Chaudhry, Rajeshwari Subramaniam, Nishant Verma, Anuj Singh · 2026
Read Gut Colonization With Carbapenem-Resistant Enterobacteriaceae in COVID-19-Recovered Patients: A Prospective Observational Study by Priyam Batra, Ajisha Aravindan, Priyankar K Datta, Sumit Roy Chowdhury, Rama Chaudhry, Rajeshwari Subramaniam, Nishant Verma, Anuj Singh (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13626728.txt.
Description
Priyam Batra and co-authors check gut carriage of drug resistant bacteria after COVID illness in a 2026 study. Heavy antibiotic use during the pandemic raised fears of resistant gut germs. Stool samples came from recovered patients, home controls, and hospital controls. Labs grew resistant strains and typed their resistance genes.
Two hundred sixty-six people joined across the three groups. Resistant carriage ran high in all groups, near six in ten people. Recovered patients showed no higher rate than either control group. Two resistance genes led the finds. The authors urge ongoing watch and careful antibiotic use, since carriage is widespread well beyond COVID wards.
Catalog record
| CREATOR | Priyam Batra, Ajisha Aravindan, Priyankar K Datta, Sumit Roy Chowdhury, Rama Chaudhry, Rajeshwari Subramaniam, Nishant Verma, Anuj Singh |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |